LY-3200882 Uses, Dosage, Side Effects and more

LY-3200882 is under investigation in clinical trial NCT04158700 (A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer).

Trade Name LY-3200882
Generic LY-3200882
Type
Formula C24H29N5O3
Weight Average: 435.528
Monoisotopic: 435.227039814
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share